Table of Content

1 Antiemetic Drugs Market Overview
1.1 Product Overview and Scope of Antiemetic Drugs
1.2 Antiemetic Drugs Segment by Type
1.2.1 Global Antiemetic Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Dopamine Antagonist
1.2.3 5-HT-3 Receptor Antagonist
1.2.4 NK1 Receptor Antagonist
1.2.5 Cannabinoid Receptor Antagonist
1.3 Antiemetic Drugs Segment by Application
1.3.1 Global Antiemetic Drugs Market Value by Application: (2024-2034)
1.3.2 Chemotherapy
1.3.3 Gastroenteritis
1.3.4 Surgery
1.4 Global Antiemetic Drugs Market Size Estimates and Forecasts
1.4.1 Global Antiemetic Drugs Revenue 2024-2034
1.4.2 Global Antiemetic Drugs Sales 2024-2034
1.4.3 Global Antiemetic Drugs Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Antiemetic Drugs Market Competition by Manufacturers
2.1 Global Antiemetic Drugs Sales Market Share by Manufacturers (2024-2024)
2.2 Global Antiemetic Drugs Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Antiemetic Drugs Average Price by Manufacturers (2024-2024)
2.4 Global Antiemetic Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Antiemetic Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antiemetic Drugs, Product Type & Application
2.7 Antiemetic Drugs Market Competitive Situation and Trends
2.7.1 Antiemetic Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antiemetic Drugs Players Market Share by Revenue
2.7.3 Global Antiemetic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antiemetic Drugs Retrospective Market Scenario by Region
3.1 Global Antiemetic Drugs Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Antiemetic Drugs Global Antiemetic Drugs Sales by Region: 2024-2034
3.2.1 Global Antiemetic Drugs Sales by Region: 2024-2024
3.2.2 Global Antiemetic Drugs Sales by Region: 2024-2034
3.3 Global Antiemetic Drugs Global Antiemetic Drugs Revenue by Region: 2024-2034
3.3.1 Global Antiemetic Drugs Revenue by Region: 2024-2024
3.3.2 Global Antiemetic Drugs Revenue by Region: 2024-2034
3.4 North America Antiemetic Drugs Market Facts & Figures by Country
3.4.1 North America Antiemetic Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Antiemetic Drugs Sales by Country (2024-2034)
3.4.3 North America Antiemetic Drugs Revenue by Country (2024-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antiemetic Drugs Market Facts & Figures by Country
3.5.1 Europe Antiemetic Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Antiemetic Drugs Sales by Country (2024-2034)
3.5.3 Europe Antiemetic Drugs Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antiemetic Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Antiemetic Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Antiemetic Drugs Sales by Country (2024-2034)
3.6.3 Asia Pacific Antiemetic Drugs Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antiemetic Drugs Market Facts & Figures by Country
3.7.1 Latin America Antiemetic Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Antiemetic Drugs Sales by Country (2024-2034)
3.7.3 Latin America Antiemetic Drugs Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antiemetic Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Antiemetic Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Antiemetic Drugs Sales by Country (2024-2034)
3.8.3 Middle East and Africa Antiemetic Drugs Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Antiemetic Drugs Sales by Type (2024-2034)
4.1.1 Global Antiemetic Drugs Sales by Type (2024-2024)
4.1.2 Global Antiemetic Drugs Sales by Type (2024-2034)
4.1.3 Global Antiemetic Drugs Sales Market Share by Type (2024-2034)
4.2 Global Antiemetic Drugs Revenue by Type (2024-2034)
4.2.1 Global Antiemetic Drugs Revenue by Type (2024-2024)
4.2.2 Global Antiemetic Drugs Revenue by Type (2024-2034)
4.2.3 Global Antiemetic Drugs Revenue Market Share by Type (2024-2034)
4.3 Global Antiemetic Drugs Price by Type (2024-2034)
5 Segment by Application
5.1 Global Antiemetic Drugs Sales by Application (2024-2034)
5.1.1 Global Antiemetic Drugs Sales by Application (2024-2024)
5.1.2 Global Antiemetic Drugs Sales by Application (2024-2034)
5.1.3 Global Antiemetic Drugs Sales Market Share by Application (2024-2034)
5.2 Global Antiemetic Drugs Revenue by Application (2024-2034)
5.2.1 Global Antiemetic Drugs Revenue by Application (2024-2024)
5.2.2 Global Antiemetic Drugs Revenue by Application (2024-2034)
5.2.3 Global Antiemetic Drugs Revenue Market Share by Application (2024-2034)
5.3 Global Antiemetic Drugs Price by Application (2024-2034)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
6.1.4 GlaxoSmithKline Antiemetic Drugs Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Johnson & Johnson Antiemetic Drugs Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Pfizer Antiemetic Drugs Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Sanofi Antiemetic Drugs Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Corporation Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Abbott Antiemetic Drugs Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Bristol-Myers Squibb Antiemetic Drugs Product Portfolio
6.6.5 Bristol-Myers Squibb Recent Developments/Updates
6.7 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Cipla Antiemetic Drugs Product Portfolio
6.7.5 Cipla Recent Developments/Updates
6.8 Eisai
6.8.1 Eisai Corporation Information
6.8.2 Eisai Description and Business Overview
6.8.3 Eisai Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Eisai Antiemetic Drugs Product Portfolio
6.8.5 Eisai Recent Developments/Updates
6.9 Eli Lilly
6.9.1 Eli Lilly Corporation Information
6.9.2 Eli Lilly Description and Business Overview
6.9.3 Eli Lilly Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Eli Lilly Antiemetic Drugs Product Portfolio
6.9.5 Eli Lilly Recent Developments/Updates
6.10 Glenmark
6.10.1 Glenmark Corporation Information
6.10.2 Glenmark Description and Business Overview
6.10.3 Glenmark Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Glenmark Antiemetic Drugs Product Portfolio
6.10.5 Glenmark Recent Developments/Updates
6.11 Helsinn Healthcare
6.11.1 Helsinn Healthcare Corporation Information
6.11.2 Helsinn Healthcare Antiemetic Drugs Description and Business Overview
6.11.3 Helsinn Healthcare Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Helsinn Healthcare Antiemetic Drugs Product Portfolio
6.11.5 Helsinn Healthcare Recent Developments/Updates
6.12 Heron Therapeutics
6.12.1 Heron Therapeutics Corporation Information
6.12.2 Heron Therapeutics Antiemetic Drugs Description and Business Overview
6.12.3 Heron Therapeutics Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Heron Therapeutics Antiemetic Drugs Product Portfolio
6.12.5 Heron Therapeutics Recent Developments/Updates
6.13 IPCA Laboratories
6.13.1 IPCA Laboratories Corporation Information
6.13.2 IPCA Laboratories Antiemetic Drugs Description and Business Overview
6.13.3 IPCA Laboratories Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
6.13.4 IPCA Laboratories Antiemetic Drugs Product Portfolio
6.13.5 IPCA Laboratories Recent Developments/Updates
6.14 Lupin
6.14.1 Lupin Corporation Information
6.14.2 Lupin Antiemetic Drugs Description and Business Overview
6.14.3 Lupin Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Lupin Antiemetic Drugs Product Portfolio
6.14.5 Lupin Recent Developments/Updates
6.15 Merck
6.15.1 Merck Corporation Information
6.15.2 Merck Antiemetic Drugs Description and Business Overview
6.15.3 Merck Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
6.15.4 Merck Antiemetic Drugs Product Portfolio
6.15.5 Merck Recent Developments/Updates
6.16 Novartis
6.16.1 Novartis Corporation Information
6.16.2 Novartis Antiemetic Drugs Description and Business Overview
6.16.3 Novartis Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
6.16.4 Novartis Antiemetic Drugs Product Portfolio
6.16.5 Novartis Recent Developments/Updates
6.17 RedHill
6.17.1 RedHill Corporation Information
6.17.2 RedHill Antiemetic Drugs Description and Business Overview
6.17.3 RedHill Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
6.17.4 RedHill Antiemetic Drugs Product Portfolio
6.17.5 RedHill Recent Developments/Updates
6.18 Sun Pharmaceutical Industries
6.18.1 Sun Pharmaceutical Industries Corporation Information
6.18.2 Sun Pharmaceutical Industries Antiemetic Drugs Description and Business Overview
6.18.3 Sun Pharmaceutical Industries Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
6.18.4 Sun Pharmaceutical Industries Antiemetic Drugs Product Portfolio
6.18.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.19 Takeda Pharmaceutical
6.19.1 Takeda Pharmaceutical Corporation Information
6.19.2 Takeda Pharmaceutical Antiemetic Drugs Description and Business Overview
6.19.3 Takeda Pharmaceutical Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
6.19.4 Takeda Pharmaceutical Antiemetic Drugs Product Portfolio
6.19.5 Takeda Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antiemetic Drugs Industry Chain Analysis
7.2 Antiemetic Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antiemetic Drugs Production Mode & Process
7.4 Antiemetic Drugs Sales and Marketing
7.4.1 Antiemetic Drugs Sales Channels
7.4.2 Antiemetic Drugs Distributors
7.5 Antiemetic Drugs Customers
8 Antiemetic Drugs Market Dynamics
8.1 Antiemetic Drugs Industry Trends
8.2 Antiemetic Drugs Market Drivers
8.3 Antiemetic Drugs Market Challenges
8.4 Antiemetic Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Antiemetic Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Antiemetic Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Antiemetic Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Antiemetic Drugs Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Antiemetic Drugs Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Antiemetic Drugs Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Antiemetic Drugs Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Antiemetic Drugs Average Price (USD/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Antiemetic Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Antiemetic Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Antiemetic Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Antiemetic Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antiemetic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiemetic Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antiemetic Drugs Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Antiemetic Drugs Sales by Region (2024-2024) & (K Units)
Table 18. Global Antiemetic Drugs Sales Market Share by Region (2024-2024)
Table 19. Global Antiemetic Drugs Sales by Region (2024-2034) & (K Units)
Table 20. Global Antiemetic Drugs Sales Market Share by Region (2024-2034)
Table 21. Global Antiemetic Drugs Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Antiemetic Drugs Revenue Market Share by Region (2024-2024)
Table 23. Global Antiemetic Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Antiemetic Drugs Revenue Market Share by Region (2024-2034)
Table 25. North America Antiemetic Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Antiemetic Drugs Sales by Country (2024-2024) & (K Units)
Table 27. North America Antiemetic Drugs Sales by Country (2024-2034) & (K Units)
Table 28. North America Antiemetic Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Antiemetic Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Antiemetic Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Antiemetic Drugs Sales by Country (2024-2024) & (K Units)
Table 32. Europe Antiemetic Drugs Sales by Country (2024-2034) & (K Units)
Table 33. Europe Antiemetic Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Antiemetic Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Antiemetic Drugs Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Antiemetic Drugs Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Antiemetic Drugs Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Antiemetic Drugs Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Antiemetic Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Antiemetic Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Antiemetic Drugs Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Antiemetic Drugs Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Antiemetic Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Antiemetic Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Antiemetic Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Antiemetic Drugs Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Antiemetic Drugs Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Antiemetic Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Antiemetic Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Antiemetic Drugs Sales (K Units) by Type (2024-2024)
Table 51. Global Antiemetic Drugs Sales (K Units) by Type (2024-2034)
Table 52. Global Antiemetic Drugs Sales Market Share by Type (2024-2024)
Table 53. Global Antiemetic Drugs Sales Market Share by Type (2024-2034)
Table 54. Global Antiemetic Drugs Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Antiemetic Drugs Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Antiemetic Drugs Revenue Market Share by Type (2024-2024)
Table 57. Global Antiemetic Drugs Revenue Market Share by Type (2024-2034)
Table 58. Global Antiemetic Drugs Price (USD/Unit) by Type (2024-2024)
Table 59. Global Antiemetic Drugs Price (USD/Unit) by Type (2024-2034)
Table 60. Global Antiemetic Drugs Sales (K Units) by Application (2024-2024)
Table 61. Global Antiemetic Drugs Sales (K Units) by Application (2024-2034)
Table 62. Global Antiemetic Drugs Sales Market Share by Application (2024-2024)
Table 63. Global Antiemetic Drugs Sales Market Share by Application (2024-2034)
Table 64. Global Antiemetic Drugs Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Antiemetic Drugs Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Antiemetic Drugs Revenue Market Share by Application (2024-2024)
Table 67. Global Antiemetic Drugs Revenue Market Share by Application (2024-2034)
Table 68. Global Antiemetic Drugs Price (USD/Unit) by Application (2024-2024)
Table 69. Global Antiemetic Drugs Price (USD/Unit) by Application (2024-2034)
Table 70. GlaxoSmithKline Corporation Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 73. GlaxoSmithKline Antiemetic Drugs Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. Johnson & Johnson Corporation Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 78. Johnson & Johnson Antiemetic Drugs Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 83. Pfizer Antiemetic Drugs Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Sanofi Corporation Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 88. Sanofi Antiemetic Drugs Product
Table 89. Sanofi Recent Developments/Updates
Table 90. Abbott Corporation Information
Table 91. Abbott Description and Business Overview
Table 92. Abbott Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 93. Abbott Antiemetic Drugs Product
Table 94. Abbott Recent Developments/Updates
Table 95. Bristol-Myers Squibb Corporation Information
Table 96. Bristol-Myers Squibb Description and Business Overview
Table 97. Bristol-Myers Squibb Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 98. Bristol-Myers Squibb Antiemetic Drugs Product
Table 99. Bristol-Myers Squibb Recent Developments/Updates
Table 100. Cipla Corporation Information
Table 101. Cipla Description and Business Overview
Table 102. Cipla Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 103. Cipla Antiemetic Drugs Product
Table 104. Cipla Recent Developments/Updates
Table 105. Eisai Corporation Information
Table 106. Eisai Description and Business Overview
Table 107. Eisai Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 108. Eisai Antiemetic Drugs Product
Table 109. Eisai Recent Developments/Updates
Table 110. Eli Lilly Corporation Information
Table 111. Eli Lilly Description and Business Overview
Table 112. Eli Lilly Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 113. Eli Lilly Antiemetic Drugs Product
Table 114. Eli Lilly Recent Developments/Updates
Table 115. Glenmark Corporation Information
Table 116. Glenmark Description and Business Overview
Table 117. Glenmark Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 118. Glenmark Antiemetic Drugs Product
Table 119. Glenmark Recent Developments/Updates
Table 120. Helsinn Healthcare Corporation Information
Table 121. Helsinn Healthcare Description and Business Overview
Table 122. Helsinn Healthcare Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 123. Helsinn Healthcare Antiemetic Drugs Product
Table 124. Helsinn Healthcare Recent Developments/Updates
Table 125. Heron Therapeutics Corporation Information
Table 126. Heron Therapeutics Description and Business Overview
Table 127. Heron Therapeutics Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 128. Heron Therapeutics Antiemetic Drugs Product
Table 129. Heron Therapeutics Recent Developments/Updates
Table 130. IPCA Laboratories Corporation Information
Table 131. IPCA Laboratories Description and Business Overview
Table 132. IPCA Laboratories Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 133. IPCA Laboratories Antiemetic Drugs Product
Table 134. IPCA Laboratories Recent Developments/Updates
Table 135. Lupin Corporation Information
Table 136. Lupin Description and Business Overview
Table 137. Lupin Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 138. Lupin Antiemetic Drugs Product
Table 139. Lupin Recent Developments/Updates
Table 140. Merck Corporation Information
Table 141. Merck Description and Business Overview
Table 142. Merck Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 143. Merck Antiemetic Drugs Product
Table 144. Merck Recent Developments/Updates
Table 145. Novartis Corporation Information
Table 146. Novartis Description and Business Overview
Table 147. Novartis Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 148. Novartis Antiemetic Drugs Product
Table 149. Novartis Recent Developments/Updates
Table 150. RedHill Corporation Information
Table 151. RedHill Description and Business Overview
Table 152. RedHill Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 153. RedHill Antiemetic Drugs Product
Table 154. RedHill Recent Developments/Updates
Table 155. Sun Pharmaceutical Industries Corporation Information
Table 156. Sun Pharmaceutical Industries Description and Business Overview
Table 157. Sun Pharmaceutical Industries Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 158. Sun Pharmaceutical Industries Antiemetic Drugs Product
Table 159. Sun Pharmaceutical Industries Recent Developments/Updates
Table 160. Takeda Pharmaceutical Corporation Information
Table 161. Takeda Pharmaceutical Description and Business Overview
Table 162. Takeda Pharmaceutical Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 163. Takeda Pharmaceutical Antiemetic Drugs Product
Table 164. Takeda Pharmaceutical Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Antiemetic Drugs Distributors List
Table 168. Antiemetic Drugs Customers List
Table 169. Antiemetic Drugs Market Trends
Table 170. Antiemetic Drugs Market Drivers
Table 171. Antiemetic Drugs Market Challenges
Table 172. Antiemetic Drugs Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antiemetic Drugs
Figure 2. Global Antiemetic Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Antiemetic Drugs Market Share by Type in 2022 & 2034
Figure 4. Dopamine Antagonist Product Picture
Figure 5. 5-HT-3 Receptor Antagonist Product Picture
Figure 6. NK1 Receptor Antagonist Product Picture
Figure 7. Cannabinoid Receptor Antagonist Product Picture
Figure 8. Global Antiemetic Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Antiemetic Drugs Market Share by Application in 2022 & 2034
Figure 10. Chemotherapy
Figure 11. Gastroenteritis
Figure 12. Surgery
Figure 13. Global Antiemetic Drugs Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 14. Global Antiemetic Drugs Market Size (2024-2034) & (US$ Million)
Figure 15. Global Antiemetic Drugs Sales (2024-2034) & (K Units)
Figure 16. Global Antiemetic Drugs Average Price (USD/Unit) & (2024-2034)
Figure 17. Antiemetic Drugs Report Years Considered
Figure 18. Antiemetic Drugs Sales Share by Manufacturers in 2022
Figure 19. Global Antiemetic Drugs Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Antiemetic Drugs Players: Market Share by Revenue in 2022
Figure 21. Antiemetic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 22. Global Antiemetic Drugs Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 23. North America Antiemetic Drugs Sales Market Share by Country (2024-2034)
Figure 24. North America Antiemetic Drugs Revenue Market Share by Country (2024-2034)
Figure 25. U.S. Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 26. Canada Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 27. Europe Antiemetic Drugs Sales Market Share by Country (2024-2034)
Figure 28. Europe Antiemetic Drugs Revenue Market Share by Country (2024-2034)
Figure 29. Germany Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. France Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. U.K. Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. Italy Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Russia Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Asia Pacific Antiemetic Drugs Sales Market Share by Region (2024-2034)
Figure 35. Asia Pacific Antiemetic Drugs Revenue Market Share by Region (2024-2034)
Figure 36. China Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. Japan Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. South Korea Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. India Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. Australia Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Taiwan Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. Indonesia Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Thailand Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Malaysia Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Philippines Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Latin America Antiemetic Drugs Sales Market Share by Country (2024-2034)
Figure 47. Latin America Antiemetic Drugs Revenue Market Share by Country (2024-2034)
Figure 48. Mexico Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Brazil Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Argentina Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. Middle East & Africa Antiemetic Drugs Sales Market Share by Country (2024-2034)
Figure 52. Middle East & Africa Antiemetic Drugs Revenue Market Share by Country (2024-2034)
Figure 53. Turkey Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 54. Saudi Arabia Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 55. U.A.E Antiemetic Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 56. Global Sales Market Share of Antiemetic Drugs by Type (2024-2034)
Figure 57. Global Revenue Market Share of Antiemetic Drugs by Type (2024-2034)
Figure 58. Global Antiemetic Drugs Price (USD/Unit) by Type (2024-2034)
Figure 59. Global Sales Market Share of Antiemetic Drugs by Application (2024-2034)
Figure 60. Global Revenue Market Share of Antiemetic Drugs by Application (2024-2034)
Figure 61. Global Antiemetic Drugs Price (USD/Unit) by Application (2024-2034)
Figure 62. Antiemetic Drugs Value Chain
Figure 63. Antiemetic Drugs Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed